SCHEMBL31024364

SCHEMBL31024364

CC(C)(C)OC(=O)N1CCC(COCC2CCN(C(=O)c3ccc(Cl)c(N4CCC(=O)NC4=O)c3)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ PDK3 Q15120 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ NOTCH1 P46531 1/20 0.40
▸ CRBN Q96SW2 6/20 0.40
▸ DDB1 Q16531 5/20 0.40
▸ ABL1 P00519 1/20 0.39
▸ RIN1 Q13671 1/20 0.39
▸ GPR119 Q8TDV5 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ CHEK2 O96017 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27124609 1.00 MEN1 (0.42) MEN1KMT2APDK1PDK2PDK3
SCHEMBL31024377 0.94 MEN1 (0.39) MEN1KMT2APDK1PDK2PDK3
SCHEMBL31024352 0.93 GPR119 (0.45) MEN1KMT2APDK1PDK2PDK3
SCHEMBL29892557 0.92 GPR119 (0.43) MEN1KMT2APDK1PDK2PDK3
SCHEMBL27137616 0.92 CRBN (0.39) MEN1KMT2APDK1PDK2PDK3
SCHEMBL23123648 0.90 CNR1 (0.43) MEN1KMT2APDK1PDK2PDK3
SCHEMBL31161308 0.90 CNR1 (0.43) MEN1KMT2APDK1PDK2PDK3
SCHEMBL26099471 0.89 MEN1 (0.52) MEN1KMT2APDK1PDK2PDK3
SCHEMBL23121362 0.89 KMT2A (0.44) MEN1KMT2APDK1PDK2PDK3
SCHEMBL31677220 0.89 MEN1 (0.41) MEN1KMT2APDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240261418-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) 2024-08-08 — — US disclosed
US-20240261417-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) 2024-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240261418-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SOS1, RAC1, RSU1 MEN1 805/4885KMT2A 4200/4885PDK1 2819/4885
US-20240261417-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF RAC1, SOS1, RSU1 MEN1 920/4885KMT2A 4157/4885PDK1 2514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback